Vivesto Logo

Vivesto

Develops and licenses novel cancer therapies for humans and animals using proprietary drug delivery.

VIVE | ST

Overview

Corporate Details

ISIN(s):
SE0000722365 (+4 more)
LEI:
5493003TZPR4B7QO9L49
Country:
Sweden
Address:
Box 3061, 169 03 SOLNA
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Vivesto is a specialty pharmaceutical company focused on developing novel treatment options for patients with advanced and hard-to-treat cancers. The company's strategy involves advancing a portfolio of projects to address significant unmet medical needs in both human and veterinary oncology. Vivesto utilizes proprietary drug delivery technologies, such as its XR-17 platform, to improve the formulation and intravenous administration of established and new drugs. Key activities include the development and global out-licensing of its proprietary drug candidates, including products like Apealea and the veterinary candidate Paccal Vet. Formerly known as Oasmia, the company is dedicated to improving survival rates and the quality of life for cancer patients.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-12 08:00
Interim Report
Swedish 640.9 KB
2025-05-08 10:30
Post-Annual General Meeting Information
Kommuniké från årsstämma i Vivesto AB
Swedish 54.9 KB
2025-05-08 10:30
Post-Annual General Meeting Information
Report from Annual General Meeting in Vivesto AB
English 54.6 KB
2025-05-08 08:00
Quarterly Report
Swedish 612.7 KB
2025-03-18 07:15
M&A Activity
Vivesto licenses Apealea to China’s Zhida Pharmaceutical
English 64.5 KB
2025-03-18 07:15
Regulatory News Service
Vivesto utlicensierar Apealea till kinesiska Zhida Pharmaceutical
Swedish 64.9 KB
2025-02-20 08:00
Earnings Release
Swedish 935.6 KB
2024-11-21 08:00
Quarterly Report
Swedish 3.4 MB
2024-11-07 10:54
M&A Activity
Vivesto signs Apealea option agreement with Zhida Pharmaceutical
English 63.9 KB
2024-11-07 10:54
Regulatory News Service
Vivesto ingår optionsavtal för Apealea med Zhida Pharmaceutical
Swedish 64.3 KB
2024-08-22 08:00
Interim Report
Swedish 917.1 KB
2024-05-23 10:48
Post-Annual General Meeting Information
Report from Annual General Meeting in Vivesto AB
English 55.7 KB
2024-05-23 10:48
Post-Annual General Meeting Information
Kommuniké från årsstämma i Vivesto AB
Swedish 55.7 KB
2024-05-23 08:00
Quarterly Report
Swedish 900.5 KB
2024-04-23 08:05
Annual Report
Swedish 13.4 MB

Automate Your Workflow. Get a real-time feed of all Vivesto filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Vivesto via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2021-08-19 Anders Härfstrand Other Buy 20,000 53,132.58 SEK
2021-07-16 Peter Zonabend Other Buy 100,000 302,623.60 SEK
2021-07-14 Fredrik Järrsten Other Buy 20,000 58,200.00 SEK
2021-07-13 Francois-Regis Martelet Other Buy 41,000 121,370.00 SEK
2021-07-08 Birgit Agneta Stattin Norinder Other Buy 35,000 104,480.00 SEK
2021-07-06 Anders Härfstrand Other Buy 100,000 285,653.00 SEK
2020-10-13 Francois-Regis Martelet Other Buy 20,000 85,000.00 SEK
2020-10-12 Anders Härfstrand Other Buy 30,000 130,800.00 SEK
2020-06-18 Sven Rohmann Other Sell 100,000 620,638.00 SEK
2020-06-18 Sven Rohmann Other Sell 78,370 504,702.80 SEK

Peer Companies

Company Country Ticker View
Y-Biologics, Inc Logo
Develops novel antibody cancer therapies using proprietary T-cell engager & antibody library tech.
South Korea 338840
Yellow Balloon Tour Co., Ltd. Logo
Offers domestic & international travel packages, flights, and tours for individuals and groups.
South Korea 104620
Yoshimura Food Holdings K.K. Logo
Acquires and revitalizes Japanese food SMEs via a support platform for global expansion.
Japan 2884
Ziccum AB Logo
Licenses ambient drying tech for pharma to create stable, cold-chain-free biologics.
Sweden ZICC
グロービング株式会社 Logo
Accelerates business growth via strategic consulting, AI implementation, and proprietary SaaS.
Japan 277A
株式会社D&Mカンパニー Logo
Optimizing healthcare & welfare businesses via finance, consulting, and HR solutions.
Japan 189A
株式会社Veritas In Silico Logo
An in silico drug discovery platform creating mRNA-targeting medicines with pharma partners.
Japan 130A
株式会社タイミー Logo
On-demand staffing platform connecting businesses and workers for flexible spot work.
Japan 215A
株式会社ユカリア Logo
Management, DX, and data solutions for healthcare and long-term care providers.
Japan 286A
株式会社レント Logo
Rents industrial & construction machinery and provides inspection services for various industries.
Japan 372A

Talk to a Data Expert

Have a question? We'll get back to you promptly.